# Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants

> **NCT00636285** · PHASE1 · COMPLETED · sponsor: **Biosynexus Incorporated** · enrollment: 8 (actual)

## Conditions studied

- Staphylococcal Sepsis

## Interventions

- **DRUG:** Placebo
- **DRUG:** BSYX-A110
- **DRUG:** BSYX-A110

## Key facts

- **NCT ID:** NCT00636285
- **Lead sponsor:** Biosynexus Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2001-09
- **Final completion:** 2001-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2008-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00636285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00636285, "Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00636285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*